Apolipoprotein E polymorphisms and age at first coronary artery bypass graft

Anesthesia and Analgesia

Volumn 92, Issue 4, 2001, Pages 824-829

  Newman, Mark F ^a   Laskowitz, Daniel T ^a   White, William D ^a   Kirchner, Jerry L ^a   Grocott, Hilary P ^a   Stafford Smith, Mark ^a   Sketch, Michael H ^a   Jones, Robert H ^a   Reves, J G ^a   Saunders, Ann M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGE; AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035083467     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200104000-00006     Document Type: Article

References (45)

1. The pathogenesis of atherosclerosis
2. Phenotypic effects of apolipoprotein structural variation on lipid profiles. III. Contribution of apolipoprotein E phenotype to prediction of total cholesterol, apolipoprotein B, and low density lipoprotein cholesterol in the Healthy Women Study
3. Apolipoprotein E polymorphism and atherosclerosis
4. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site
5. Lipoprotein receptors and cholesterol homeostasis
6. Abnormal in vivo metabolism of apolipoprotein E4 in humans
7. The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of apolipoprotein B containing lipoproteins in humans
8. Apolipoprotein E polymorphism and atherosclerosis: Insight from a study in octogenarians
9. Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease
10. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations: The EARS study
11. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease
12. Apolipoprotein E polymorphism, serum lipids, myocardial infarction and severity of angiographically verified coronary artery disease in men and women
13. Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease
14. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: The Framingham Offspring Study
15. Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: An autopsy study
16. Relation of genetic polymorphisms of apolipoprotein E, angiotensin converting enzyme, apolipoprotein B-100, and glycoprotein IIIa and early-onset coronary heart disease
17. The role of the apolipoprotein E polymorphism in the prediction of coronary artery disease age of onset
18. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
19. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation
20. Apolipoprotein E polymorphisms affect atherosclerosis in young males: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group
21. Binding of the human apolipoprotein E to synthetic amyloid beta peptide: Isoform specific effects and implications for late-onset Alzheimer disease
22. Clinical chemistry of common apolipoprotein E isoforms
23. Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults
24. The underlying molecular mechanism of apolipoprotein E polymorphism: Relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease
25. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease
26. Apolipoprotein E genotypes in offspring with a positive and negative family history of premature myocardial infarction
27. Apolipoprotein E suppresses phytohemagglutinin-activated phospholipid turnover in peripheral blood mononuclear cells
28. Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In
29. Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production
30. Apolipoprotein E suppresses glial cell secretion of TNF alpha
31. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
32. Apolipoprotein E inhibits platelet-derived growth factor-induced vascular smooth muscle cell migration and proliferation by suppressing signal transduction and preventing cell entry to G1 phase
33. Low-dose expression of a human apolipoprotein E transgene in macrophages restores cholesterol efflux capacity of apolipoprotein E-deficient mouse plasma
34. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis: Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum
35. Increased plasma and lipoprotein lipid preoxidation in aop E-deficient mice
36. Angiotensin-converting enzyme and apolipoprotein E genotypes and restenosis after coronary angioplasty
37. Apolipoprotein epsilon 4 homozygosity: A determinant of restenosis after coronary angioplasty
38. Apolipoprotein E polymorphism does not predict risk of restenosis after coronary angioplasty
39. Increased frequency of apolipoprotein epsilon 2 allele in non-insulin dependent diabetic (NIDDM) patients with nephropathy
40. Association of apolipoprotein epsilon2 allele with diabetic nephropathy in Caucasian subjects with IDDM
41. Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischemic stroke
42. Genetic predictors of common disease: Apolipoprotein E genotype as a paradigm
43. Genetic associations with human longevity at the APOE and ACE loci
44. Apolipoprotein E polymorphism is not associated with longevity or disability in a sample of Italian octo- and nonagenarians